This Kalorama Information report, Needle-Free Drug Delivery: The Market for Alternatives to Needle-Based Systems for Vaccines and Biologics, takes a look at this aspect of the pharmaceutical marketplace, with figures and forecasts for pharmaceutical companies and the companies that supply technology to them. The report discusses how the success of specific drugs will be tied to innovative delivery techniques, which will enable the targeting that will exploit the clinical properties of a new generation of drugs.
The development of better delivery systems in conjunction with the discovery of novel pharmacological compounds will lead to significant improvements in drug delivery. This report looks at that trend and provides current and forecasted revenues for the injectable drug delivery market, segmented into two main categories:
This breakout makes the report relevant to business plans of either device technology companies or pharmaceutical concerns. In addition, the following key information for business planners is included in the report:
Companies Profiled in the report include:
All Kalorama reports advertise the single user price, which limits access to one user. We also feature department and global pricing for reports that will be utilized by more than one user at your company. Please ask your sales representative or select the correct license on our website.
For Kalorama's take on the healthcare news of the week, based on our analysis of healthcare markets, follow Kalorama Information's Key Point Blog at http://kaloramakeypoint.blogspot.com/
Needle-Free Drug Delivery: The Market for Alternatives to Needle-Based Sys...
July 01, 2011
Or leave us a message and we'll call you back!
Receive bi-weekly email alerts for new market research.